Screening of cognition – what are alternatives to MMSE?

Česká verzia

Authors: E. Panenková
Authors place of work: FN Motol, Praha, Katedra psychologie, Filozofická fakulta UK, Praha
Published in the journal: Geriatrie a Gerontologie 2019, 8, č. 4: 149-153
Category: Review Article

Summary

We often need an approximate estimate of the patient’s cognitive performance in clinical practice. Screening tests of cognition are used for the detection of cognitive impairment. There are many reasons why to use these instrumentse.g. saving time, less demands on neuropsychological experience or better price compared to complex neuropsychological examination. The most used method in the Czech Republic is the Mini Mental State Examination(MMSE). Using this tool has benefits and limits. In our context we can use Montreal Cognitive Assessment, 7-Minute Screen (7MST), Clock Drawing Test (CDT), Addenbrooke’s Cognitive Examination-Revised (ACE-R). The aim of this study is providean up-to-date information on the various studies on the field of screening methods, especially in the context of the Czech population and highlight new normative data and the possibilities of each screening application.

Keywords:

mild cognitive impairment – screening of cognition – syndrom of dementia – Mini-Mental State Examination

Zdroje

1. Státní ústav pro kontrolu léčiv (online) (cit. 2019-09-19). Dostupné z: http://www.sukl.cz

2. Vyhnálek M, Bartoš A, Dostál V, et al. Diagnostikujeme a léčíme demence správně a včas? Výsledky průzkumu ve světle nových doporučení. Neurologie pro praxi 2011; 12(5): 352–358.

3. Folstein M, Folstein S, Hugh PM. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal od psychiatric research 1975; 12: 189–198.

4. Anthony JC, Leresche L, Niaz U, et al. Limits of the ,Mini-Mental State‘ as a screening test for dementia and delirium among hospital patients. Psychological Medicine 1982; 12(2): 397–408.

5. Tošnerová T, Bahbouh R. Mini-mental state – rychlé orientační vyšetření kognitivního stavu. Československá psychologie 1998; 42(4): 328–333.

6. Panenková E, Štěpánková H, Kopeček M. Národní Normativní Studie Kognitivních Determinant Zdravého Stárnutí. In: Stárnutí 2012 Sborník příspěvků (online). Psychiatrické centrum Praha 2012: s. 95–99.

7. Štěpánková H, Nikolai T, Bezdíček O, et al. Mini-Mental State Examination – Česká Normativní Studie. Cesk Slov Neurol N 2015; 78(111): 57–63.

8. Nasreddine Z, Phillips N, Badirian V, et al. The Montreal Cognitive Assessment, Moca: A Brief Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc 2005; 53(4): 695–699.

9. Damian A, Jacobson, S, Hentz J, et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores. Dementia and Geriatric Cognitive Disorders 2011; 31(2): 126–131.

10. Nazem S, Siderowf A, Duda J, et al. Montreal Cognitive Assessment Performance In Patients With Parkinson‘s Disease With „Normal“ Global Cognition According To Mini-Mental State Examination Score. J Am Geriatr Soc 2009; 57(2): 304–308.

11. Lessig S, Nie D, Xu R, et al. Changes on brief cognitive instruments over time in Parkinson‘s disease. Mov Disord 2012; 27(9): 1125–1128.

12. Ciesielska N, Sokołowski R, Mazur E. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatria Polska 2016; 50(5): 1039–1052.

13. Reban J. Montrealský kognitivní test/MoCA/: přínos k diagnostice predemencí. Čes Ger Rev 2006; 4: 224–229.

14. Kopeček M, Štěpánková H, Panenková E, et al. Montrealský kognitivní test (MOCA) a MMSE – české normy. Česk Slov Neurol N: Suppl 2 2013; 76(109): 226–227.

15. Bezdíček O, Georgi H, Panenková E, et al. Equivalence of Montreal Cognitive Assessment alternate forms. Česká a slovenská neurologie a neurochirurgie 2019; 82/115(3): 332–340.

16. Bezdíček, O, Balabánová P, Havránková P, et al. Srovnání české verze Montrealského kognitivního testu s Mini-Mental State pro stanovení kognitivního deficitu u Parkinsonovy nemoci. Česká a slovenská neurologie a neurochirurgie 2010; 73106(2): 150–156.

17. Bezdíček O, Majerová V, Novák M, et al. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington’s disease. Appl Neuropsychol Adul 2013; 20(1): 33–40.

18. Kopecek M, Stepankova H, Lukavsky J, et al. Montreal cognitive assessment (MoCA): Normative data for old and very old Czech adults. Applied Neuropsychology: Adult 2016; 24(1): 23–29.

19. Horton D, Hynan L, Lacritz L, et al. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening. The Clinical Neuropsychologist 2015; 29(4): 413–425.

20. Roalf D, Moore T, Wolk D, et al. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology, Neurosurgery & Psychiatry 2016; 87:1303–1310.

21. Bezdicek O, Červenková M, Tyler Moore M, et al. Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson’s Disease and Cross-Cultural Comparison. Assessment 2018.

22. Panenková E, Kopeček M, Lukavský J. Položková analýza a možnosti zkrácení Montrealského kognitivního testu. Česká a slovenská psychiatrie 2016; 112(2): 63–69.

23. Solomon P, Pendlebury W. Recognition of Alzheimer’s disease: the 7 Minute Screen. Fam Med 1998; 30(4): 265–271.

24. Rektorová I. Screeningové škály pro hodnocení demence. Neurologie pro praxi 2011; 12: 37–45.

25. Topinková E, Jirák R, Kožený J. Krátká neurokognitivní baterie pro sceening demence v klinické praxi: Sedmiminutový screeningový test. Neurologie pro praxi 2002; 6: 323–328.

26. Meulen E, Schmand B, van Campen J, et al. The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. Journal of Neurology, Neurosurgery & Psychiatry 2004;75:700–705.

27. Drake M, Butman J, Fontan L, et al. Screening for mild cognitive impairment: usefulness of the 7-Minute Screen test. Actas Espanolas de Psiquiatria 2003; 31(5): 252–255.

28. Nanda KS, Swetha S. Comparison of the Montreal Cognitive Assessment and 7minute Screen Test to Assess Mild Cognitive Impairment Among Geriatric Population. Asian Pacific Journal of Health Sciences 2018; 5(4): 119–128.

29. Mathuranath P, Nestor PJ, Berrios G, et al. A brief cognitive test battery to differentiate Alzheimer‘s disease and frontotemporal dementia. Neurology 2000; 55(11): 1613–1620.

30. Raisová M, Kopeček M, Řípová D, et al. Addenbrookský kognitivní test a jeho možnosti použití v lékařské praxi. Psychiatrie 2011; 15(3); 145–150.

31. Hummelová-Fanfrdlová Z, Rektorová I, Sheardová K, et al. Česká adaptace Addenbrookského kognitivního testu. Československá psychologie 2009; 53(4): 376-388.

32. Bartoš A, Raisová M, Kopeček M. Novelizace české verze Addenbrookského kognitivního testu (ACE-CZ). Česká a Slovenská neurologie a neurochirurgie 2011; 74/107(6): 681-684.

33. Beránková D, Krulová P, Mračková M, et al. Addenbrookský kognitivní test – orientační normy pro českou populaci. Cesk Slov Neurol N 2015; 78/111(3): 300-305.

34. Roncato S, Sartori G, Masterson J, et al. Constructional apraxia: An information processing analysis. Cognitive Neuropsychology 1987; 4(2): 113–129.

35. Shulman K. Clock-drawing: is it the ideal cognitive screening test?. International Journal of Geriatric Psychiatry 2000; 15(6): 548–561.

36. Vyhnálek M, Rubínová E, Marková H, et al. Clock drawing test in screening for Alzheimer‘s dementia and mild cognitive impairment in clinical practice. International Journal of Geriatric Psychiatry 2017; 32(9): 933–939.

37. Mazancova Fendrych A, Nikolai T, Stepankova H, et al. The Reliability of Clock Drawing Test Scoring Systems Modeled on the Normative Data in Healthy Aging and Nonamnestic Mild Cognitive Impairment. Assessment 2016; 24(7): 945–957.

38. Rakusa M, Jensterle J, Mlakar A. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia. Dementia and Geriatric Cognitive Disorders 2018; 45(5–6): 326–334.

39. Rubínová E, Nikolai T, Marková H, et al. Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: Can more detailed scoring systems do the work?. Journal of Clinical and Experimental Neuropsychology 2014; 36(10): 1076–1083.

40. Babins L, Slater ME, Whitehead V, et al. Can an 18-point clock-drawing scoring system predict dementia in elderly individuals with mild cognitive impairment?. Journal of Clinical and Experimental Neuropsychology 2008; 30(2): 173–186.

41. Cohen M, Ricci C, Kibby M, et al. Developmental Progression of Clock Face Drawing in Children. Child Neuropsychol 2000; 6(1); 64–76.

42. Nikolai T, Štěpánková H, Bezdíček O. Mírná kognitivní porucha a syndrom demence – vyšetření kognitivních funkcí. Med praxi 2014; 11(6): 275–277.